Echo Therapeutics Inc (ECTE) Financial Statements (2024 and earlier)

Company Profile

Business Address 99 WOOD AVENUE SOUTH
ISELIN, NJ 08830
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments93943563337469
Cash and cash equivalents93943563337469
Other undisclosed current assets263332245223343447
Total current assets:1,202375301227680917
Noncurrent Assets
Property, plant and equipment210237 302443931
Intangible assets, net (including goodwill)      9,625
Intangible assets, net (excluding goodwill)      9,625
Other noncurrent assets00000130
Assets held-for-sale, long lived2,554
Other undisclosed noncurrent assets251137236(66)(264)(3,485)
Total noncurrent assets:4603742372371809,755
Other undisclosed assets210237268302443931
TOTAL ASSETS:1,8719868057651,30411,602
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,9992,4622,7782,2332,1651,734
Accounts payable1,6151,9982,1761,9161,5141,369
Accrued liabilities384464602318651365
Debt2,351868    
Derivative instruments and hedges, liabilities4,6871,6031272706353,309
Other undisclosed current liabilities1127293302946213
Total current liabilities:9,1495,6623,2352,5322,8465,256
Noncurrent Liabilities
Liabilities, other than long-term debt969696969696
Deferred revenue and credits969696969696
Total noncurrent liabilities:969696969696
Total liabilities:9,2455,7583,3312,6282,9415,351
Equity
Equity, attributable to parent, including:(7,374)(4,772)(2,526)(1,862)(1,690)6,251
Preferred stock, shares subscribed but unissued, subscriptions receivable    (300)  
Common stock115114111111111111
Additional paid in capital148,123147,785147,413147,101145,256142,312
Accumulated deficit(155,692)(152,751)(150,130)(148,854)(147,078)(136,236)
Other undisclosed equity, attributable to parent808080802163
Other undisclosed equity     52 
Total equity:(7,374)(4,772)(2,526)(1,862)(1,638)6,251
TOTAL LIABILITIES AND EQUITY:1,8719868057651,30411,602

Income Statement (P&L) ($ in thousands)

9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
Revenues1,087 81 250 
Financial services revenue1,087(325) (54)250 
Cost of revenue
(Financial Services Costs)
      (5,534)
Other undisclosed gross profit   4,620   
Gross profit:1,087 4,701 250(5,534)
Operating expenses(1,482)(1,656)(1,297)(1,458)(12,276)(2,509)
Other undisclosed operating income (loss)(1,087)325(4,701)54(250)5,534
Operating loss:(1,482)(1,656)(1,297)(1,458)(12,276)(2,509)
Nonoperating income (expense)(1,459)(965)24(317)1,433(5,795)
Debt instrument, convertible, beneficial conversion feature  (155)    
Other nonoperating income (expense)    (263)8 
Interest and debt expense(107)(39)(10)(0)(2)(3)
Income (loss) from continuing operations before income taxes:(3,048)(2,660)(1,283)(1,776)(10,845)(8,306)
Other undisclosed loss from continuing operations   (3)   
Income (loss) from continuing operations:(3,048)(2,660)(1,287)(1,776)(10,845)(8,306)
Income (loss) before gain (loss) on sale of properties:(3,048)(2,660)(1,287)(1,776)(10,845)(8,306)
Net income (loss):(3,048)(2,660)(1,287)(1,776)(10,845)(8,306)
Other undisclosed net income attributable to parent1073910023
Net income (loss) attributable to parent:(2,941)(2,621)(1,276)(1,775)(10,843)(8,304)
Preferred stock dividends and other adjustments (6,461)     
Net income (loss) available to common stockholders, diluted:(9,402)(2,621)(1,276)(1,775)(10,843)(8,304)

Comprehensive Income ($ in thousands)

9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
12/31/2015
Q4
9/30/2015
Q3
6/30/2015
Q2
3/31/2015
Q1
Net income (loss):(3,048)(2,660)(1,287)(1,776)(10,845)(8,306)
Comprehensive income (loss), net of tax, attributable to parent:(3,048)(2,660)(1,287)(1,776)(10,845)(8,306)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: